AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson’s disease.

Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial

PHILADELPHIA — An oral investigational aldosterone synthase inhibitor (ASI) cut albuminuria by nearly 40% in people in chronic kidney disease (CKD) in a phase II

November 7, 2023

Smart Eye Will Monitor Driver’s Vital Signs to Enhance Road Safety

What You Should Know: Smart Eye, a developer of Driver Monitoring System (DMS) technology for the automotive industry adds vital signs detection that analyzes multiple

June 23, 2023

Orexo announces NDA submission for opioid overdose therapy

OX124 is expected to reverse the effects of synthetic opioids such as fentanyl. Credit: Your Hand Please/Shutterstock.com. Orexo has submitted a new drug application (NDA)

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.